Health TrialsbyHealthPanel

The Impact of Synergies of Indoor Air Pollutants on Childhood Health and Wellbeing

ConditionsPollution; ExposureEnvironmental ExposureChildhood AsthmaChildhood
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age8-9
SponsorNational and Kapodistrian University of Athens

About this trial

To quantify health effects of synergizing chemical and biological pollutants in a targeted population setting, i.e., school-aged children. Indoor air pollutants will be monitored within the classrooms with high end sensors. Exposure data from additional sources (outdoor, home, transports) will be obtained. Health outcomes will be assessed prospectively using validated medical procedures and real-time tracking with mobile health (mHealth) equipment and a gamified computer app.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Students of primary schools aged 8-9 years.

The subject and/or legal custodian have the verbal, writing and mental ability to understand the intent and character of the study.

Written informed consent from the child's parents/guardian's

Disqualifiers

None

Trial population

Children at this age have the ability to understand the character of the study, to handle the app and the wearables, to successfully perform lung function and airway inflammation measurements (as it has been ascertained in the previous FP7\_PreDicta and Horizon\_CURE projects), to cooperate with blood sampling, while not being yet subjective to hormonal changes of puberty. Moreover, students at this age mainly attend lessons in the same class, thus exposures in the school environment are considered stable,

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • SynAir-Child

    Device

    Monitor the indoor pollutants and their effect on children well being

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Respiratory, mental health

Questionnaires

Time frame
One year
2

Immune health

RNA Sequency/CRP

Time frame
One year
3

Oxidative stress

DNA damage levels in blood cells

Time frame
One year
4

Lung function and

Spirometry

Time frame
One year

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

National and Kapodistrian University of Athens

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: